Potential interactions between exercise and drug therapy
about
Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.Investigation of gene expression in C(2)C(12) myotubes following simvastatin application and mechanical strain.Characterizing variability in warfarin dose requirements in children using modelling and simulation.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Impact of regular physical activity on weekly warfarin dose requirement.The Effect of Atorvastatin on Habitual Physical Activity among Healthy Adults.Hypertension and aging.Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.Patient variation in veterinary medicine--part II--influence of physiological variables.The effects of high physical activity on pharmacokinetic drug interactions.A review of psychophysiological stressors on pharmacokinetics.Adverse drug reaction and concepts of drug safety in Ayurveda: An overview.Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity.Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity.Sunscreens in human plasma and urine after repeated whole-body topical application.Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans.The effect of operational stressors on ibuprofen pharmacokinetics.
P2860
Q33415287-0DAC874C-B713-41FE-BA2A-2F9C1CB295F1Q33837541-6903BBBD-6B05-4FD8-99AE-DCF8FBDF7C4DQ34209582-51CA47FC-8641-43EE-AB23-001EA999BAB9Q34252907-675A4A27-1F4C-4C3E-B452-0529E9A23861Q35735988-556F8D10-E2FD-4261-8B8F-CEDD56F17B5CQ36378125-2E2C2374-F9D1-46FE-9B3A-4055473F3DC6Q36623143-2D84C5A4-7BFA-4A16-8388-013371A18272Q37372721-6CF9AE33-A5A1-4595-97D6-F57F24A0E3C5Q37376879-3F95EDB6-A8BE-479E-81D4-FA77FE934DC6Q37810325-236C3231-5413-4689-9297-BB7A6FEC8D20Q37829750-334DAD51-ECDE-4A3C-95AF-E1351A2ACAA4Q37831732-B1D846B8-3001-40CB-94DD-350A714BC301Q38190536-6A27F693-8730-4F20-96EA-6EF0C3A1855BQ38953706-9D6DF247-8EFF-46E1-86D8-064D032FA8D5Q44237828-387626BE-FD51-41F4-96FD-358F08A92F74Q46686112-FDDF75D1-2C5F-470A-B10C-52ED0B8C45D2Q46790433-BE81A602-0ACF-40EF-8195-FC685A6BE4A3Q46808863-5D74D61A-0309-4D0C-8508-BE125E7CC2F2Q47683541-9FBAC552-C46B-40B0-A6EE-1AAAEE13214D
P2860
Potential interactions between exercise and drug therapy
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Potential interactions between exercise and drug therapy
@ast
Potential interactions between exercise and drug therapy
@en
Potential interactions between exercise and drug therapy
@nl
type
label
Potential interactions between exercise and drug therapy
@ast
Potential interactions between exercise and drug therapy
@en
Potential interactions between exercise and drug therapy
@nl
prefLabel
Potential interactions between exercise and drug therapy
@ast
Potential interactions between exercise and drug therapy
@en
Potential interactions between exercise and drug therapy
@nl
P2093
P1433
P1476
Potential interactions between exercise and drug therapy
@en
P2093
Michele A Faulkner
Nancy J Lenz
Thomas L Lenz
P2860
P304
P356
10.2165/00007256-200434050-00002
P407
P577
2004-01-01T00:00:00Z
P6179
1022411256